by David Wagner | Oct 17, 2022 | Blog, Macro Updates
When someone says, “It’s football season”, Kentuckians, in their own dialect, instantaneously translate that to “Keeneland is about to open”. Even more exciting this year, the racetrack will be getting an extra weekend of fun with the ’22 Breeders Cup being raced the...
by David Wagner | Oct 10, 2022 | Market Updates
“O Muse!, Sing in me, and through me, tell the story, Of that skilled investor, in all ways of contending, An asset allocation, searching for alpha years on end…” -Invocation of Muse An Invocation of Muse serves as a prologue of events to come, famously used by...
by David Wagner | Oct 4, 2022 | Blog, Market Updates
Developments Over the Past Month Can you Hear the Fed Now? September 2022 Market Recap: At the end of September, the Fed removed any remaining doubt about its commitment to getting inflation under control. As a result, both bonds and stocks sold off sharply....
by David Wagner | Sep 26, 2022 | Blog, Macro Updates
Many of y’all have heard my D + G spiel regarding the S&P 500’s P/E compressing from 21.5x (Dec ’21) to 16x currently, all while the risk premium has actually tightened. In other words, the cheapening of the P/E simply reflects the reality of higher real interest...
by David Wagner | Sep 5, 2022 | Equity Case Studies, Equity Research, Research Reports
With this Aptus Musing focusing on the stock of the month, I thought I’d review the stock that has the least amount of U.S. exposure in our Compounders Portfolio – NVIDIA Corporation (NVDA). See the compliance approved Case Study here. But, before we start our dive on...
